Review



plasmids expressing pcdna3  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc plasmids expressing pcdna3
    A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag <t>pcDNA3</t> (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.
    Plasmids Expressing Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmids expressing pcdna3/product/Addgene inc
    Average 93 stars, based on 7 article reviews
    plasmids expressing pcdna3 - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer"

    Article Title: Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

    Journal: bioRxiv

    doi: 10.1101/2022.01.14.476328

    A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag pcDNA3 (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.
    Figure Legend Snippet: A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag pcDNA3 (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.

    Techniques Used: Expressing, Transformation Assay, Isolation, Quantitative RT-PCR, Sequencing, DNA Amplification, Gene Expression, Control, Western Blot, Software, Luciferase, Activity Assay, Transfection, Plasmid Preparation, Reporter Assay



    Similar Products

    93
    Addgene inc plasmids expressing pcdna3
    A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag <t>pcDNA3</t> (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.
    Plasmids Expressing Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmids expressing pcdna3/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plasmids expressing pcdna3 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Addgene inc sost pcdna3 1 expression vector
    A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag <t>pcDNA3</t> (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.
    Sost Pcdna3 1 Expression Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sost pcdna3 1 expression vector/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    sost pcdna3 1 expression vector - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Addgene inc sost expression plasmid
    Wnt signaling-induced upregulation of TNF-α was antagonized by DKK and Sclerostin <t>(SOST).</t> (A – E) Nucleus pulposus cells were transfected with the TNF-α reporter construct and increasing concentrations of the WT-DKK plasmids (100 to 500 ng) or empty backbone plasmids (A : DKK-1, B : DKK-2, C : DKK-3, D : DKK-4, E : SOST). (F - H) The TNF-α reporter plasmid was transfected into nucleus pulposus cells together with the PGL4.74 vector, and was stimulated with 6-bromoindirubin-3′-oxime (BIO) in the presence or absence of DKK expression plasmids. Luciferase activity was measured 24 h after transfection (F : DKK-3, G : DKK-4, H : SOST). * P <0.05 indicates significant differences between groups. n.s., not significant.
    Sost Expression Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sost expression plasmid/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    sost expression plasmid - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag pcDNA3 (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.

    Journal: bioRxiv

    Article Title: Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

    doi: 10.1101/2022.01.14.476328

    Figure Lengend Snippet: A and B , Expression of ESR1 and ESR2 in immortalized mammary MCF10A, transformed ERα+ MCF7 and T47D, endocrine resistant MCF7-TamR, MCF7-FasR, T47D-TamR, and T47D-FasR, CDK6 over-expressing MCF7 (MCF7-CDK6 O/E), CDK4/6 inhibitor resistant MCF7 (MCF7-CDK4/6iR) and T47D (T47D-CDK4/6iR), ZR-75-1, and triple negative breast cancer (TNBC; MDA-MB231, MDA-MB-468, Hs578t) cell lines. Total RNA was isolated from the established cell lines using TRIzol. The expression of each gene was assessed by quantitative RT-PCR (qRT-PCR) performed with the DNase-treated RNA samples using gene-specific primers spanning exon-exon junctions that include large introns in the corresponding genomic sequence to avoid genomic DNA amplification. Gene expression was calculated by ΔΔCt method using GAPDH as an internal control. The expression of each gene is shown as the fold change relative to MCF10A. All reactions were done in triplicate and the experiment was repeated twice. Data were plotted as mean ± SD. A , ESR2 genes; full length (left) and all isoforms (right). B , ESR1 . C , whole-cell lysates were extracted and immunoblot analyses were performed for ERβ and GAPDH (loading control) (upper panel), and ERα and GAPDH (lower panel). Intensity of the protein bands was quantified using Image Studio (LiCor) software. Numbers under the lanes of each cell line represent normalized values of the corresponding protein band (ERβ or ERα). Normalized band intensity of MCF10A was considered as 1. Immunoblot analyses were repeated twice with corresponding biological replicates. Reproducible results were obtained in each independent experiment. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. For ERβ (upper panel) two different exposures were provided; low exp.= low exposure; high exp.= higher exposure of the blot D, ERE-Luciferase driven promoter activity upon treatment with selective ERβ agonists is significantly higher in ectopically expressing cells with ERβ compared to that of ERα . HEK293T cells were transfected with c-Flag pcDNA3 (vector control), c-Flag ERα or c-Flag ERβ in combination with ERE-Luciferase (reporter) and TK-renilla (pRLTK; internal control) plasmids (as described in Materials and Methods section). Forty eight hours after treatment of the cells with ERβ specific agonists Renilla and Firefly luciferase activities were measured using the dual-luciferase reporter assay system. Renilla luciferase was normalized to Firefly luciferase. Treatment with: OSU-ERb-12 (0-10 μmol/L) (left) and LY500307 (0-10 μmol/L) (middle). Each assay was performed in triplicate with three experimental replicates. (mean + SD, *: p<0.05, **: p<0.01). Right panel shows equal expression of ERα and ERβ as determined by western blot analysis using anti-flag antibody. Intensity of Flag-ERα/ERβ was normalized to GAPDH. The numbers under the corresponding protein band represent normalized values of the corresponding protein band intensity.

    Article Snippet: Plasmids expressing pcDNA3 (OHu23619C; pcDNA3.1+: RRID: Addgene_10842), ERβ (OHu25562C; pcDNA3.1+), c-Flag pcDNA3 (OHu23619D; pcDNA3.1+/C-(K) DYK), c-Flag ERα (OHu26586D; pcDNA3.1+/C-(K) DYK), and c-Flag ERβ (OHu25562D; pcDNA3.1+/C-(K) DYK were obtained from GenScript.

    Techniques: Expressing, Transformation Assay, Isolation, Quantitative RT-PCR, Sequencing, DNA Amplification, Gene Expression, Control, Western Blot, Software, Luciferase, Activity Assay, Transfection, Plasmid Preparation, Reporter Assay

    Wnt signaling-induced upregulation of TNF-α was antagonized by DKK and Sclerostin (SOST). (A – E) Nucleus pulposus cells were transfected with the TNF-α reporter construct and increasing concentrations of the WT-DKK plasmids (100 to 500 ng) or empty backbone plasmids (A : DKK-1, B : DKK-2, C : DKK-3, D : DKK-4, E : SOST). (F - H) The TNF-α reporter plasmid was transfected into nucleus pulposus cells together with the PGL4.74 vector, and was stimulated with 6-bromoindirubin-3′-oxime (BIO) in the presence or absence of DKK expression plasmids. Luciferase activity was measured 24 h after transfection (F : DKK-3, G : DKK-4, H : SOST). * P <0.05 indicates significant differences between groups. n.s., not significant.

    Journal: Arthritis Research & Therapy

    Article Title: A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cells

    doi: 10.1186/ar4379

    Figure Lengend Snippet: Wnt signaling-induced upregulation of TNF-α was antagonized by DKK and Sclerostin (SOST). (A – E) Nucleus pulposus cells were transfected with the TNF-α reporter construct and increasing concentrations of the WT-DKK plasmids (100 to 500 ng) or empty backbone plasmids (A : DKK-1, B : DKK-2, C : DKK-3, D : DKK-4, E : SOST). (F - H) The TNF-α reporter plasmid was transfected into nucleus pulposus cells together with the PGL4.74 vector, and was stimulated with 6-bromoindirubin-3′-oxime (BIO) in the presence or absence of DKK expression plasmids. Luciferase activity was measured 24 h after transfection (F : DKK-3, G : DKK-4, H : SOST). * P <0.05 indicates significant differences between groups. n.s., not significant.

    Article Snippet: K3-luc (TNF-α promoter element; number 11110) and the SOST expression plasmid (number 10842) were purchased from Addgene (Cambridge, MA, USA).

    Techniques: Transfection, Construct, Plasmid Preparation, Expressing, Luciferase, Activity Assay

    Effect of TNF-α on Wnt signaling in nucleus pulposus cells. (A - B) Cells transfected with the Topflash reporter plasmid (A) or the Fopflash plasmid (B) together with the pGL4.74 plasmid were treated with different concentrations of TNF-α for 6 to 12 h. (C) Nucleus pulposus cells were transfected with the Topflash reporter plasmid or the Fopflash reporter plasmid and increasing concentrations of the Sclerostin (SOST) plasmids (100 to 500 ng) or empty backbone plasmids. (D) SOST mRNA expression after exposure of nucleus pulposus cells to TNF-α (10 ng/mL) for 24 h, as assessed by real-time PCR. * P <0.05 indicates significant differences between groups. Error bars represent the SD. n.s., not significant.

    Journal: Arthritis Research & Therapy

    Article Title: A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cells

    doi: 10.1186/ar4379

    Figure Lengend Snippet: Effect of TNF-α on Wnt signaling in nucleus pulposus cells. (A - B) Cells transfected with the Topflash reporter plasmid (A) or the Fopflash plasmid (B) together with the pGL4.74 plasmid were treated with different concentrations of TNF-α for 6 to 12 h. (C) Nucleus pulposus cells were transfected with the Topflash reporter plasmid or the Fopflash reporter plasmid and increasing concentrations of the Sclerostin (SOST) plasmids (100 to 500 ng) or empty backbone plasmids. (D) SOST mRNA expression after exposure of nucleus pulposus cells to TNF-α (10 ng/mL) for 24 h, as assessed by real-time PCR. * P <0.05 indicates significant differences between groups. Error bars represent the SD. n.s., not significant.

    Article Snippet: K3-luc (TNF-α promoter element; number 11110) and the SOST expression plasmid (number 10842) were purchased from Addgene (Cambridge, MA, USA).

    Techniques: Transfection, Plasmid Preparation, Expressing, Real-time Polymerase Chain Reaction